BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24161383)

  • 1. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application.
    Achilli C; Grandi S; Ciana A; Guidetti GF; Malara A; Abbonante V; Cansolino L; Tomasi C; Balduini A; Fagnoni M; Merli D; Mustarelli P; Canobbio I; Balduini C; Minetti G
    Nanomedicine; 2014 Apr; 10(3):589-97. PubMed ID: 24161383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One step synthesis of
    Kuthala N; Shanmugam M; Yao CL; Chiang CS; Hwang KC
    Biomaterials; 2022 Nov; 290():121861. PubMed ID: 36302304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets.
    Achilli C; Jadhav SA; Guidetti GF; Ciana A; Abbonante V; Malara A; Fagnoni M; Torti M; Balduini A; Balduini C; Minetti G
    Chem Biol Drug Des; 2014 May; 83(5):532-40. PubMed ID: 24666508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
    Matsuya Y; Fukunaga H; Omura M; Date H
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
    Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The basis and advances in clinical application of boron neutron capture therapy.
    He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
    Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglycerol Functionalized
    Wang Y; Reina G; Kang HG; Chen X; Zou Y; Ishikawa Y; Suzuki M; Komatsu N
    Small; 2022 Sep; 18(37):e2204044. PubMed ID: 35983628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
    Nakashima H
    Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
    Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
    J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
    Luderer MJ; de la Puente P; Azab AK
    Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
    Barth RF; Soloway AH; Brugger RM
    Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron-Containing MOF Nanoparticles with Stable Metabolism in U87-MG Cells Combining Microdosimetry To Evaluate Relative Biological Effectiveness of Boron Neutron Capture Therapy.
    Wang Z; Lei R; Zhang Z; Chen Z; Zhang J; Mao M; Li J; Tang H; Li M; Luo X; Yang J; Yan R; Liu Q; Lv L; Chen K; Chang YN; Yuan H; Liu T; Tong J; Zhu L; Liang T; Zhang W; Li J; Xing G
    ACS Appl Mater Interfaces; 2024 Jan; 16(3):3232-3242. PubMed ID: 38221726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.
    Coderre JA; Turcotte JC; Riley KJ; Binns PJ; Harling OK; Kiger WS
    Technol Cancer Res Treat; 2003 Oct; 2(5):355-75. PubMed ID: 14529302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boronated compounds for imaging guided BNCT applications.
    Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
    Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron phenyl alanine targeted chitosan-PNIPAAm core-shell thermo-responsive nanoparticles: boosting drug delivery to glioblastoma in BNCT.
    Soleimanbeigi M; Dousti F; Hassanzadeh F; Mirian M; Varshosaz J; Kasesaz Y; Rostami M
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1607-1623. PubMed ID: 35060826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.